szintetikus levegŐ siad túlnyomásos orvosi gáz
siad hungary kft. - oxygen; nitrogen -
docetaxel mylan
mylan s.a.s. - docetaxel - head and neck neoplasms; carcinoma, non-small-cell lung; adenocarcinoma; prostatic neoplasms; breast neoplasms - daganatellenes szerek - az emlőrák, a tüdőrák (nem kissejtes tüdőrák) speciális formái, a prosztatarák, a gyomorrák vagy a fej- és nyakrák.
jayempi
nova laboratories ireland limited - azatioprin - graft visszautasítás - immunszuppresszánsok - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.
docetaxel accord 40 mg/ml koncentrátum és oldószer oldatos infúzióhoz
accord healthcare ltd. - docetaxel -
docetaxel polpharma 40 mg/ml koncentrátum és oldószer oldatos infúzióhoz
polpharma s.a. - docetaxel -
taxegis 40 mg/ml koncentrátum és oldószer oldatos infúzióhoz
egis gyógyszergyár zrt. - docetaxel -
taxegis 80 mg koncentrátum és oldószer oldatos infúzióhoz
egis gyógyszergyár zrt. - docetaxel -
dynepo
shire pharmaceutical contracts limited - epoetin delta - kidney failure, chronic; anemia - antianémiás készítmények - a dynepo felnőtt betegek krónikus veseelégtelenségével (crf) szenvedő tünetekkel járó vérszegénység kezelésére javallt. dialízisben és dialízisben nem részesülő betegeknél alkalmazható.
epidyolex
jazz pharmaceuticals ireland limited - cannabidiol - lennox gastaut syndrome; epilepsies, myoclonic - antiepileptikumok, - epidyolex javallott használni, mint kiegészítő terápia a rohamok kapcsolódó lennox-gastaut szindróma (lgs) vagy dravet-szindróma (ds), együtt clobazam, a betegek számára a 2 éves vagy annál idősebb.
adtralza
leo pharma a/s - tralokinumab - dermatitis, atopic - egyéb bőrgyógyászati készítmények - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.